Burling Wealth Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.3M Sell
19,428
-3,060
-14% -$378K 0.37% 65
2025
Q4
$2.83M Sell
22,488
-7,308
-25% -$953K 0.44% 55
2025
Q3
$4.36M Buy
29,796
+2,696
+10% +$408K 0.72% 39
2025
Q2
$4.23M Buy
27,100
+4,880
+22% +$774K 0.78% 38
2025
Q1
$3.66M Buy
22,220
+9,639
+77% +$1.6M 0.77% 44
2024
Q4
$2.05M Buy
+12,581
New +$2.25M 0.42% 64

Other funds holding ZTS

Burling Wealth Partners's ZTS Position: Q1 2026 in Review

Burling Wealth Partners reduced its Zoetis (ZTS) stake by 14% in Q1 2026, selling an estimated $378K and leaving 19,428 shares worth $2.3M. The position accounts for 0.37% of the portfolio, ranked #65.

Burling Wealth Partners first reported a position in ZTS in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.36M in Q3 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Burling Wealth Partners held 19,428 shares of Zoetis worth $2.3M as of Q1 2026.
  • Burling Wealth Partners sold 3,060 Zoetis shares in Q1 2026, an estimated $378K.
  • Zoetis made up 0.37% of Burling Wealth Partners's portfolio in Q1 2026, its #65 holding.
  • Burling Wealth Partners first reported a position in Zoetis in Q4 2024 and has held it in 6 quarters since.
  • Burling Wealth Partners's Zoetis position peaked at $4.36M in Q3 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Burling Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.